Phase II Clinical Trial – CFN Media

Healthcare Stocks

Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

Topline Results Expected in Q2 2024 This is a Designated News Release.…

Ryan Allway
February 21, 2024

Tryp Therapeutics Announces Interim Results for Its Phase II Clinical Trial for the Treatment of Binge Eating Disorder With Psilocybin-Assisted Psychotherapy

Interim data analysis supports the potential effectiveness of psilocybin-assisted psychotherapy for the…

Ryan Allway
January 5, 2023

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

New Interview with Aduro’s Executive Team Sheds Light on Commercialization

Aduro Clean Technologies Inc. (NASDAQ: ADUR) (CSE: ACT) (FSE: 9D5) have begun…

Robin Lefferts
November 26, 2024

Interview with Cardiol Therapeutics’ CEO David Elsley

Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) is a life sciences company…

Robin Lefferts
November 26, 2024

Leef Brands Takes the Glass House Model to Extracts

Most investors in the cannabis space are familiar with Glass House Brands…

Robin Lefferts
November 25, 2024

Top News

International Land Alliance Announces Third Quarter Results

SAN DIEGO, CALIFORNIA, Nov. 21, 2024 (GLOBE NEWSWIRE) — International Land…

Ryan Allway
November 21, 2024